Galapagos NV
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of …
Biotechnology
BE, Mechelen [HQ]
GLPGF/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million EUR. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 93.00 | 122.00 | 95.00 | 136.00 | 137.00 | 69.00 | 39.00 | 129.00 | 127.00 | 288.00 | 844.00 | 478.00 | 484.00 | 505.00 | 239.00 | |
|
EPS
|
0.14 | 0.17 | -1.25 | -0.22 | -0.28 | 1.10 | -3.32 | 1.18 | -2.34 | -0.56 | 2.60 | -4.69 | -1.58 | -3.32 | 3.21 | |
| Diluted in mil. | 0.13 | 0.17 | -1.25 | -0.22 | -0.28 | 1.10 | -3.32 | 1.14 | -2.34 | -0.56 | 2.60 | -4.69 | -1.58 | -3.32 | 3.21 | |
|
Profit
|
7.00 | 6.00 | -29.00 | 88.00 | 96.00 | -41.00 | -90.00 | -10.00 | -91.00 | -34.00 | 417.00 | -45.00 | 483.00 | 493.00 | 203.00 | |
| Gross Margin | 8.59 | 5.22 | -30.35 | 64.64 | 70.01 | -60.17 | -227.87 | -7.77 | -71.93 | -11.79 | 49.43 | -9.54 | 99.66 | 97.61 | 84.99 | |
| Pre Tax | 1.00 | - - | -33.00 | -5.00 | -11.00 | -35.00 | -119.00 | 54.00 | -115.00 | -29.00 | 150.00 | -309.00 | -122.00 | -215.00 | 5.00 | |
| Profit Margin | 1.81 | 0.48 | -35.17 | -3.78 | -8.13 | -50.75 | -302.37 | 41.88 | -90.89 | -10.11 | 17.76 | -64.80 | -25.37 | -42.58 | 2.34 | |
| ETR | -78.58 | -643.20 | 1.87 | -11.04 | 27.83 | -5.97 | 1.02 | 0.43 | -0.17 | -0.17 | 0.14 | -0.40 | -1.97 | -1.32 | 171.43 | |
| Net | 3.00 | 4.00 | -33.00 | -5.00 | -8.00 | 33.00 | -118.00 | 54.00 | -115.00 | -29.00 | 149.00 | -305.00 | -103.00 | -217.00 | 211.00 | |
| Profit Margin | 3.23 | 3.57 | -34.52 | -4.20 | -5.87 | 47.88 | -299.29 | 41.70 | -91.04 | -10.13 | 17.73 | -63.89 | -21.29 | -43.14 | 88.32 | |
| EBITDA | 9.00 | 14.00 | -19.00 | 8.00 | -1.00 | -29.00 | -55.00 | -5.00 | -82.00 | -35.00 | 390.00 | -165.00 | -138.00 | -194.00 | 34.00 | |
| EBITDA Margin | 10.34 | 11.62 | -20.84 | 6.25 | -1.33 | -42.27 | -140.05 | -4.40 | -65.24 | -12.14 | 46.17 | -34.60 | -28.46 | -38.41 | 14.51 | |
| Operating Income | 1.00 | 1.00 | -32.00 | -6.00 | -11.00 | -36.00 | -89.00 | -11.00 | -89.00 | -44.00 | 370.00 | -178.00 | -165.00 | -276.00 | -135.00 | |
| Operating Margin | 1.78 | 0.84 | -34.35 | -4.85 | -8.00 | -52.80 | -226.08 | -8.87 | -70.66 | -15.51 | 43.82 | -37.37 | -34.15 | -54.73 | -56.57 | |
| Interest Income | - - | 1.00 | - - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 3.00 | 5.00 | 14.00 | 10.00 | 2.00 | 18.00 | 79.00 | |
| Loss | -91.00 | -120.00 | -128.00 | -138.00 | -147.00 | -105.00 | -129.00 | -141.00 | -216.00 | -333.00 | -474.00 | -656.00 | -650.00 | -772.00 | -375.00 | |
| Cost of Revenue | -85.00 | -116.00 | -124.00 | -48.00 | -41.00 | -111.00 | -129.00 | -139.00 | -218.00 | -322.00 | -427.00 | -523.00 | -1.00 | -12.00 | -35.00 | |
|
Operating Expenses
|
-6.00 | -4.00 | -3.00 | -90.00 | -106.00 | -105.00 | -129.00 | -141.00 | -216.00 | -333.00 | -474.00 | -656.00 | -648.00 | -760.00 | -375.00 | |
| R&D | - - | - - | - - | -80.00 | -99.00 | -111.00 | -129.00 | -139.00 | -218.00 | -322.00 | -427.00 | -523.00 | -491.00 | -515.00 | -241.00 | |
| G&A | -16.00 | -21.00 | -23.00 | -18.00 | -19.00 | -8.00 | -19.00 | -15.00 | -17.00 | -25.00 | -63.00 | -95.00 | -97.00 | -185.00 | -92.00 | |
| SG&A | -19.00 | -24.00 | -25.00 | -20.00 | -21.00 | -9.00 | -20.00 | -16.00 | -20.00 | -29.00 | -88.00 | -162.00 | -167.00 | -239.00 | -134.00 | |
| S&M | -2.00 | -2.00 | -2.00 | -2.00 | -2.00 | - - | -1.00 | -1.00 | -2.00 | -4.00 | -24.00 | -66.00 | -69.00 | -54.00 | -1.00 | |
| Depreciation and Amortization | -6.00 | -11.00 | -12.00 | -9.00 | -8.00 | -4.00 | -3.00 | -4.00 | -4.00 | -5.00 | -12.00 | -18.00 | -34.00 | -65.00 | -43.00 | |
| Interest Expenses | - - | -1.00 | -1.00 | - - | - - | - - | - - | - - | - - | - - | -1.00 | -9.00 | -11.00 | -6.00 | -1.00 | |
| Other Expenses | - - | - - | - - | -4.00 | -1.00 | -1.00 | -30.00 | -64.00 | -27.00 | -11.00 | -226.00 | -116.00 | -61.00 | -51.00 | -141.00 | |
|
WA Shares Outstanding
|
21.00 | 24.00 | 26.00 | 26.00 | 28.00 | 30.00 | 35.00 | 45.00 | 49.00 | 52.00 | 57.00 | 65.00 | 65.00 | 65.00 | 65.00 | |
| Diluted | 21.00 | 24.00 | 26.00 | 26.00 | 28.00 | 30.00 | 35.00 | 45.00 | 49.00 | 52.00 | 57.00 | 65.00 | 65.00 | 65.00 | 65.00 |